20 results
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Agents for COVID ... 2020 #Drugs #Medications ... #Treatment #COVID19 ... #Pharmacology # ... Table #Management
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Each class of medications ... #pharmacology #pharmacotherapy ... #table #comparison ... #management #medications ... endocrinology #treatment
A summary of the pharmacologic management of acute bleeding and secondary prevention of bleeds in LVAD
summary of the pharmacologic ... management of acute ... Anti-secretory Agents ... #Management #Treatment ... #Medications #Secondary
Neurological Side Effects of Antipsychotic Drugs
Acute dystonia - Spasm of muscles of tongue, face, neck, back
reduction; change medication ... tremor ("rabbit syndrome ... months or years of treatment ... #SideEffects #pharmacology ... #management
Behcet's Syndrome - Treatment
Ulcers:
 • Treatment: Topical steroids
 • Prevention: Colchicine
 • Azathioprine for refractory disease
Arthritis:
Behcet's Syndrome ... Topical steroids • Prevention ... Behcets #disease #Syndrome ... #Treatment #management ... #pharmacology #
Evans Syndrome Pharmacology Management 
Corticosteroids
IVIg
Rituximab
Splenectomy
Azathioprine
Cyclophosphamide
Cyclosporin
Mycophenolate
Vinka-alkaloid
Plasma exchange
Transfusion
Anticoagulation
Bone marrow stimulating agents

doi:10.3390/jcm9123851

#Evans #Syndrome #Pharmacology #Management #Medications #comparison #table
Evans Syndrome Pharmacology ... marrow stimulating agents ... #Pharmacology # ... Management #Medications ... #comparison #table
IDSA Recommendations for Preventing and Managing Cryptosporidiosis in HIV-AIDS
Preventing Chronic Cryptosporidiosis:
 • Because chronic cryptosporidiosis occurs
Recommendations for Preventing ... anti-diarrheal agent ... #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Managing Microsporidiosis in HIV-AIDS
Preventing Chronic Microsporidiosis:
 • Because chronic microsporidiosis occurs
Recommendations for Preventing ... : • The best treatment ... #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Recommendations for Preventing ... #Treatment #opportunistic ... infections #HIVAIDS #management ... #pharmacology # ... pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
chew, or crush tablet ... mucosal #IDSA #Prevention ... #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology